ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2017. The put-call ratio across all filers is 3.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $179,293 | -43.3% | 28,779 | -38.9% | 0.03% | -39.6% |
Q3 2022 | $316,000 | -64.0% | 47,138 | -65.8% | 0.05% | -37.7% |
Q2 2022 | $877,000 | +8.4% | 137,873 | -20.9% | 0.08% | +10.0% |
Q1 2022 | $809,000 | -32.8% | 174,315 | -27.6% | 0.07% | -23.9% |
Q4 2021 | $1,204,000 | -17.3% | 240,835 | +99.3% | 0.09% | -12.4% |
Q3 2021 | $1,456,000 | -34.1% | 120,828 | +15.7% | 0.10% | -28.1% |
Q2 2021 | $2,208,000 | +368.8% | 104,400 | +522.2% | 0.15% | +329.4% |
Q1 2021 | $471,000 | -90.0% | 16,778 | -81.8% | 0.03% | -89.4% |
Q2 2020 | $4,731,000 | +44.9% | 92,200 | -11.0% | 0.32% | +24.3% |
Q1 2020 | $3,265,000 | -21.1% | 103,567 | +49.2% | 0.26% | +1.6% |
Q4 2019 | $4,138,000 | +75.6% | 69,400 | +7.9% | 0.26% | +82.1% |
Q3 2019 | $2,357,000 | -21.2% | 64,306 | -0.1% | 0.14% | -20.9% |
Q2 2019 | $2,993,000 | -73.1% | 64,339 | -79.6% | 0.18% | -69.6% |
Q1 2017 | $11,126,000 | +1879.7% | 315,100 | +601.8% | 0.58% | +1475.7% |
Q4 2016 | $562,000 | -11.4% | 44,900 | -2.0% | 0.04% | 0.0% |
Q3 2016 | $634,000 | – | 45,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |